CVRdatabase
Menu

Reponex Pharmaceuticals A/S

Public limited companyCVR 30082346HørsholmActive

Reponex Pharmaceuticals A/S is a public limited company, based in Hørsholm, active in manufacture of pharmaceutical preparations, founded in 2006. The company made a loss in both 2024 and 2025, most recently DKK 6.6m. 3 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 0
Net profit−DKK 6.6m+45% vs. 2024
EquityDKK 4.6m+152.9% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 11.9m to DKK 6.6m (2024 → 2025).
  • Equity turned positive again: DKK 4.6m (2024 → 2025).

Management and owners, last 24 months

  • New in management: Christian Henrik Tange (ceo, 19/12/2025) and Sebastian Bo Jakobsen (ceo, 01/04/2025).
  • Stepped down: Thomas Kaas Selsø (ceo, 01/04/2025) and Sebastian Bo Jakobsen (ceo, 19/12/2025).

Registrations, last 24 months

  • 19/01/2026: Moved to Slotsmarken 12, 1. th, 2970 Hørsholm

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 20m−DKK 10mDKK 0DKK 10mDKK 20mDKK 30m202020212022202320242025
EquityNet profit
Financial figures for Reponex Pharmaceuticals A/S
202020212022202320242025Change
Revenue00not stated000–
Gross profit00–000–
Operating profit (EBIT)−2,302−12,604−12,043−16,600−13,507−7,693+43%
Profit before tax−2,383−12,855−12,065−16,579−13,759−7,602+44.7%
Net profit−1,505−9,883−10,210−14,346−11,943−6,570+45%
Total assets20,40928,70819,98421,6623,6317,301+101.1%
Equity13,42827,37117,37916,757−8,7854,645+152.9%
Liabilities––2,6064,90512,4162,655−78.6%
Cash and cash equivalents13611,4032,8301,93844554−87.9%
Average number of employees1––––––

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 500kDKK 1mDKK 1.5mDKK 2mDKK 2.5mDKK 3m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Reponex Pharmaceuticals A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202518/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202417/04/2025The companyPDFXBRL
202301/01/2023 – 31/12/202318/04/2024The companyPDFXBRL
202201/01/2022 – 31/12/202201/05/2023The companyPDFXBRL
202101/01/2021 – 31/12/202127/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202003/02/2022The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0246809/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 0No. 35 of 57
Better than 39% of the companies in the industry
EquityDKK 4.6mNo. 31 of 59
Better than 48% of the companies in the industry
Number of employees2No. 43 of 59
Better than 28% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bn
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 62,791of 69,742
Better than 10%
No. 14,847of 69,964
Better than 79%
Same industry and fewer than 20 employees37 companies in the comparison
No. 17of 36
Better than 54%
No. 13of 37
Better than 67%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 22,517of 24,791
Better than 9%
No. 10,095of 24,909
Better than 59%
All companies of type A/S18,025 companies in the comparison
No. 16,577of 17,786
Better than 7%
No. 11,764of 18,024
Better than 35%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Reponex Pharmaceuticals A/SDKK 0
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. Reponex Pharmaceuticals A/S−DKK 6.6m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. Reponex Pharmaceuticals A/SDKK 4.6m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. Reponex Pharmaceuticals A/S2
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Pharma Equity Group A/S100%
Reponex Pharmaceuticals A/S

Management

4 active registrations

Executive management

Executive management at Reponex Pharmaceuticals A/S
NameRoleAppointed
Christian Henrik TangeCEO19/12/2025

Board of directors

Board of directors at Reponex Pharmaceuticals A/S
NameRoleAppointed
Charlotte PahlBoard member14/05/2018
Troels Peter TroelsenDeputy chair22/06/2021
Christian Vinding ThomsenChair of the board11/10/2022
Founders
Polinvest ApS
Former management (23)
Former management at Reponex Pharmaceuticals A/S
NameRoleAppointedResigned
Mikael ThiesenDirector04/12/200615/05/2007
Jon Steffen TherkildsenDirector15/05/200731/12/2008
Michael SecherDirector31/12/200802/02/2010
Henrik Lasse LindbladCEO02/02/201019/04/2016
Troels Peter TroelsenBoard member17/03/201520/06/2016
Jacob RosenbergChair of the board17/03/201530/10/2015
Henrik BulskovBoard member17/03/201517/06/2019
Torsten BjørnDirector19/04/201601/03/2021
Troels Peter TroelsenChair of the board21/06/201616/06/2019
Erik Lennard Vitting SkovbjergBoard member21/06/201625/06/2016
Lisbeth ThyregodBoard member31/05/201727/04/2023
Troels Peter TroelsenBoard member17/06/201921/06/2021
Sigbjørn Georg Nielsen KjærgårdChair of the board17/06/201910/10/2022
Klaus Snej JensenCEO01/03/202111/10/2022
Katrine Hoff SchlichtkrullBoard member22/06/202114/10/2021
Christian Vinding ThomsenBoard member22/06/202110/10/2022
Thomas Kaas SelsøDirector01/03/202213/06/2023
Sigbjørn Georg Nielsen KjærgårdCEO11/10/202214/06/2023
Sigbjørn Georg Nielsen KjærgårdBoard member11/10/202231/03/2023
Peter Mørch EriksenBoard member31/03/202315/06/2023
Mette ZachoBoard member31/03/202327/04/2023
Thomas Kaas SelsøCEO14/06/202301/04/2025
Sebastian Bo JakobsenCEO01/04/202519/12/2025

Signing rule: Selskabet tegnes af direktøren og formanden for bestyrelsen i forening eller af den samlede bestyrelse.

Address and production units

1 active production units

Slotsmarken 12
2970 Hørsholm

Hørsholm Municipality · Postcode 2970

Other companies at the address (3)

Production units
Production unitAddressEmployeesP number
REPONEX PHARMACEUTICALS A/SSlotsmarken 12, 1. th, 2970 Hørsholm21012824587

Purpose

Selskabets formål er at drive virksomhed med at udvikle lægemidler samt dermed beslægtede aktiviteter og at være Holding virksomhed for selskaber med tilsvaren-de formål.

The purpose is quoted from the register in Danish.

Changes year by year

102 registered events
20262 changesaccounts 1 · address 1
  • Annual report for 2025 published
  • Moved to Slotsmarken 12, 1. th, 2970 Hørsholm
20255 changesmanagement 4 · accounts 1
  • Christian Henrik Tange appointed ceo
  • Sebastian Bo Jakobsen stepped down as ceo
  • Annual report for 2024 published
  • Sebastian Bo Jakobsen appointed ceo
  • Thomas Kaas Selsø stepped down as ceo
20241 changeaccounts 1
  • Annual report for 2023 published
202316 changesmanagement 9 · accounts 1 · ownership 4 · address 1 · capital 1
  • Peter Mørch Eriksen stepped down as board member
  • Thomas Kaas Selsø appointed ceo
  • Sigbjørn Georg Nielsen Kjærgård stepped down as ceo
  • Thomas Kaas Selsø stepped down as director
  • Annual report for 2022 published
  • Mette Zacho stepped down as board member
  • Lisbeth Thyregod stepped down as board member
  • Mette Zacho appointed board member
  • Peter Mørch Eriksen appointed board member
  • Sigbjørn Georg Nielsen Kjærgård stepped down as board member
  • Pharma Equity Group A/S registered as owner (100%)
  • Beier Holding ApS is no longer registered as owner
  • NIELS ERIK JESPERSEN HOLDING ApS is no longer registered as owner
  • BIOPHARMA HOLDING ApS is no longer registered as owner
  • Moved to Slotsmarken 18, 2. th, 2970 Hørsholm
  • Share capital changed from 829,541 DKK to 849,868 DKK
20229 changesmanagement 7 · accounts 2
  • Sigbjørn Georg Nielsen Kjærgård appointed board member
  • Christian Vinding Thomsen appointed chair of the board
  • Sigbjørn Georg Nielsen Kjærgård appointed ceo
  • Klaus Snej Jensen stepped down as ceo
  • Christian Vinding Thomsen stepped down as board member
  • Sigbjørn Georg Nielsen Kjærgård stepped down as chair of the board
  • Annual report for 2021 published
  • Thomas Kaas Selsø appointed director
  • Annual report for 2020 published
20218 changesmanagement 7 · capital 1
  • Katrine Hoff Schlichtkrull stepped down as board member
  • Christian Vinding Thomsen appointed board member
  • Troels Peter Troelsen appointed deputy chair
  • Katrine Hoff Schlichtkrull appointed board member
  • Troels Peter Troelsen stepped down as board member
  • Share capital changed from 602,268 DKK to 829,541 DKK
  • Klaus Snej Jensen appointed ceo
  • Torsten Bjørn stepped down as director
20199 changesownership 4 · management 4 · capital 1
  • DANISH MEDICAL CONSULTS ApS is no longer registered as owner
  • Sigbjørn Georg Nielsen Kjærgård appointed chair of the board
  • Troels Peter Troelsen appointed board member
  • Henrik Bulskov stepped down as board member
  • Troels Peter Troelsen stepped down as chair of the board
  • Beier Holding ApS registered as owner (10%)
  • Beier Holding ApS is no longer registered as owner
  • NIELS ERIK JESPERSEN HOLDING ApS registered as owner (5%)
  • Share capital changed from 534,086 DKK to 602,268 DKK
20186 changesname 1 · capital 1 · management 1 · ownership 3
  • Name changed from REPONEX PHARMACEUTICALS ApS to REPONEX PHARMACEUTICALS A/S
  • Share capital changed from 133,522 DKK to 534,086 DKK
  • Charlotte Pahl appointed board member
  • DANISH MEDICAL CONSULTS ApS registered as owner (5%)
  • DANISH MEDICAL CONSULTS ApS is no longer registered as owner
  • Beier Holding ApS registered as owner (5%)
20173 changesownership 2 · management 1
  • BIOPHARMA HOLDING ApS registered as owner (20%)
  • Lisbeth Thyregod appointed board member
  • BIOPHARMA HOLDING ApS is no longer registered as owner
201612 changescapital 2 · ownership 4 · management 6
  • Share capital changed from 131,872 DKK to 133,522 DKK
  • Share capital changed from 127,150 DKK to 131,872 DKK
  • DANISH MEDICAL CONSULTS ApS registered as owner (10%)
  • FINANSMANAGEMENT ApS is no longer registered as owner
  • DANISH MEDICAL CONSULTS ApS is no longer registered as owner
  • Erik Lennard Vitting Skovbjerg stepped down as board member
  • Troels Peter Troelsen appointed chair of the board
  • Erik Lennard Vitting Skovbjerg appointed board member
  • Troels Peter Troelsen stepped down as board member
  • CLINICURO ApS is no longer registered as owner
  • Torsten Bjørn appointed director
  • Henrik Lasse Lindblad stepped down as ceo
201513 changesownership 8 · management 4 · industry 1
  • FINANSMANAGEMENT ApS registered as owner (5%)
  • VULKAN INVEST ApS is no longer registered as owner
  • Jacob Rosenberg stepped down as chair of the board
  • DANISH MEDICAL CONSULTS ApS registered as owner (15%)
  • DANISH MEDICAL CONSULTS ApS is no longer registered as owner
  • BREGNERØDVEJ AUTO ApS is no longer registered as owner
  • VULKAN INVEST ApS registered as owner (5%)
  • DANISH MEDICAL CONSULTS ApS registered as owner (20%)
  • DANISH MEDICAL CONSULTS ApS is no longer registered as owner
  • Henrik Bulskov appointed board member
  • Jacob Rosenberg appointed chair of the board
  • Troels Peter Troelsen appointed board member
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
20146 changesownership 4 · name 1 · capital 1
  • DANISH MEDICAL CONSULTS ApS registered as owner (33.33%)
  • Name changed from TRIFOILIUM ApS to REPONEX PHARMACEUTICALS ApS
  • Share capital changed from 125,000 DKK to 127,150 DKK
  • BREGNERØDVEJ AUTO ApS registered as owner (5%)
  • BIOPHARMA HOLDING ApS registered as owner (25%)
  • CLINICURO ApS registered as owner (5%)
20121 changeaddress 1
  • Moved to Slotsmarken 12, 1. th, 2970 Hørsholm
20111 changename 1
  • Name changed from WYSPA ApS to TRIFOILIUM ApS
20102 changesmanagement 2
  • Henrik Lasse Lindblad appointed ceo
  • Michael Secher stepped down as director
20083 changesmanagement 2 · industry 1
  • Michael Secher appointed director
  • Jon Steffen Therkildsen stepped down as director
  • Industry changed to Køb og salg af egen fast ejendom (681000)
20073 changesmanagement 2 · address 1
  • Jon Steffen Therkildsen appointed director
  • Mikael Thiesen stepped down as director
  • Moved to Kongevejen 153, 2830 Virum
20062 changesfounded 1 · management 1
  • Registered as WYSPA ApS
  • Mikael Thiesen appointed director

Related companies

Same industry in Hørsholm

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction